首页> 美国卫生研究院文献>Molecules >Subchronic Toxicity Studies of Cortex Dictamni Extracts in Mice and Its Potential Hepatotoxicity Mechanisms in Vitro
【2h】

Subchronic Toxicity Studies of Cortex Dictamni Extracts in Mice and Its Potential Hepatotoxicity Mechanisms in Vitro

机译:地皮提取物对小鼠的亚慢性毒性研究及其潜在的肝毒性机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cortex Dictamni is a commonly-used traditional Chinese herbal medicine for the treatment of skin inflammation, tinea, and eczema. Recently, some studies reported that Cortex Dictamni might induce liver injury, suggesting more attention to its safety. The current study was designed to investigate subchronic toxicity of Cortex Dictamni aqueous extract (CDAE) and ethanol extract (CDEE) in mice and the potential hepatotoxicity mechanisms in vitro. Firstly, CDAE or CDEE groups were administrated with varying dosages (2.3, 4.6, or 9.2 g/kg/day, p.o.) in mice for 28 days in subchronic toxicity studies. General clinical signs and biochemical parameters were examined, and morphological analyses were conducted. Secondly, we identified the different constituents of CDAE and CDEE using HPLC-MS/MS and chose major components for further study. In order to determine the toxic components, we investigated the cytotoxicity of extracts and chosen components using CCK-8 assay in HepG2 cells. Furthermore, we explored the possible hepatotoxicity mechanisms of Cortex Dictamni using a high content analysis (HCA). The results showed that no significant differences of general clinical signs were observed in mice. Aspartate alanine aminotransferase (ALT) and aminotransferase (AST) were significantly increased in the high-dose CDAE and CDEE groups compared to the control group. Meanwhile, the absolute and relative liver weights and liver/brain ratio were significantly elevated, and histological examination of liver demonstrated cellular enlargement or nuclear shrinkage. In UPLC analysis, we compared the chemical constituents between CDAE and CDEE, and chose dictamnine, obakunone, and fraxinellone for hepatotoxicity evaluation in the in vitro studies. In the CCK-8 assay, CDAE, CDEE, dictamnine, obakunone, and fraxinellone decreased the cell viability in a dose-dependent manner after treatment for 48 h. Furthermore, the cell number decreased, while the nuclear intensity, cell membrane permeability, and concentration of reactive oxygen species were shown to increase, meanwhile, mitochondrial membrane potential was also changed in HepG2 cells following 48 h of compounds treatment using HCA. Our studies suggested that CDAE and CDEE have potential hepatotoxicity, and that the alcohol extraction process could increase toxicity. Dictamnine, obakunone, and fraxinellone may be the possible toxic components in Cortex Dictamni with dictamnine as the most potentially hepatotoxic component, whose potential hepatotoxicity mechanism may be associated with cell apoptosis. Moreover, this study could provide valuable data for clinical drug safety research of Cortex Dictamni and a good example for safety study of other Chinese herbal medicines.
机译:Cortex Dictamni是一种常用的中草药,可用于治疗皮肤发炎,癣和湿疹。最近,一些研究报告说皮质地克坦尼可能会诱发肝损伤,这表明人们对其安全性更加关注。当前的研究旨在调查皮质中Dictamni水提取物(CDAE)和乙醇提取物(CDEE)对小鼠的亚慢性毒性以及体外潜在的肝毒性机制。首先,在亚慢性毒性研究中,在小鼠中以不同剂量(2.3、4.6或9.2 g / kg /天,p.o。)施用CDAE或CDEE组,持续28天。检查一般的临床体征和生化参数,并进行形态分析。其次,我们使用HPLC-MS / MS鉴定了CDAE和CDEE的不同成分,并选择了主要成分进行进一步研究。为了确定毒性成分,我们使用HepG2细胞中的CCK-8分析了提取物和所选成分的细胞毒性。此外,我们使用高含量分析(HCA)探索了皮质Dictamni的可能的肝毒性机制。结果表明,在小鼠中未观察到一般临床症状的显着差异。与对照组相比,高剂量CDAE和CDEE组中的天冬氨酸丙氨酸氨基转移酶(ALT)和氨基转移酶(AST)显着增加。同时,肝脏的绝对和相对重量以及肝/脑比例显着升高,肝脏的组织学检查显示细胞增大或核缩小。在UPLC分析中,我们比较了CDAE和CDEE之间的化学成分,并在体外研究中选择了dictamnine,obakunone和fraxinellone进行肝毒性评估。在CCK-8分析中,治疗48小时后,CDAE,CDEE,三氢萘胺,奥巴孔农酮和fraxinellone以剂量依赖的方式降低了细胞活力。此外,细胞数量减少,而核强度,细胞膜通透性和活性氧的浓度显示增加,同时,使用HCA化合物处理48小时后,HepG2细胞的线粒体膜电位也发生了变化。我们的研究表明,CDAE和CDEE具有潜在的肝毒性,并且酒精提取过程可能会增加毒性。在地卡地尔中,地卡汀是最潜在的肝毒性成分,地西他宁,奥巴孔农酮和fraxinellone可能是皮质地卡他尼中可能的毒性成分,其潜在的肝毒性机制可能与细胞凋亡有关。此外,该研究可为Cortex Dictamni的临床药物安全性研究提供有价值的数据,并为其他中草药的安全性研究提供良好的实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号